Michael Cook (@Michael_R_Cook4) header
Michael Cook (@Michael_R_Cook4) profile picture

Assistant professor Hematology/Oncology @PennMedicine, focus in Lymphoma. Penn State '13, Temple Med '17. Fluent in Pittsburghese.

Philadelphia, PA
Joined July 2021
Photo by Michael Cook (@Michael_R_Cook4)Photo by Michael Cook (@Michael_R_Cook4)Photo by Michael Cook (@Michael_R_Cook4)Photo by Michael Cook (@Michael_R_Cook4)Photo by Michael Cook (@Michael_R_Cook4)Photo by Michael Cook (@Michael_R_Cook4)Photo by Michael Cook (@Michael_R_Cook4)
Prolonged MTR for induction and consolidation is a safe alternative treatment strategy for the management of PCNSL. ow.ly/tkO350WJ6fw #lymphoidneoplasia #lymphoma
2
4
20
2,269
Michael Cook retweeted
CD19-specific CAR T cells engineered to secrete interleukin-18 were used to treat patients with lymphoma after previous CAR T failure, with a complete or partial response of 81% and a complete response of 52%. Full trial results: nej.md/4jSiXkX
40
8
109
28,510
Michael Cook retweeted
Comparison of CAR T-cell vs. bispecific Ab as 3rd(+) line DLBCL Rx: A Meta-analysis 16 studies: 1,347 pts in pooled analysis •CAR-T: superior efficacy: ⬆️CR & pooled 1yr PFS cf bispecifics but •CAR-T exhibits ⬆️ incidence ≥G3 AEs cf bispecifics ashpublications.org/blood/ar…
14
45
3,083
Michael Cook retweeted
And the total for THON 2024, Treasure Every Adventure, is $16,955,683.63
5
308
118
846
160,831
Michael Cook retweeted
If there’s not a graphic, depicting the three Steelers QBs as the ghosts of Christmas past, present and future, I’m going to be v disappointed.
2
4
1
35
9,636
Exciting news! We've established a groundbreaking collaboration with the University of Pennsylvania's (UPenn) School of Clinical Medicine as part of our Centres of Excellence (CoE) programme. ​ We can't wait to see how this collaboration will take us closer to a cure for FL!
1
13
623
Michael Cook retweeted
#ASH23 continues to amaze with surprise meetups on hallways and sidewalks!! So nice to see you both @ErikaHaydu @MassGeneralNews and @Michael_R_Cook4 @PennMedicine Good old @ASCO @AACR #Vail2021 company!! @VUMCHemOnc
1
1
6
882
Michael Cook retweeted
Thanks to @michael_r_cook4, of @PennMedicine, for joining us during @ASH_hematology to speak about the impact of bridging therapy prior to axi-cel in R/R LBCL! Head to our site to see how day 1 of the meeting wraps! #ASH23 #lymsm onclive.com/conference/ash
1
950
Come join us at #ASH23 at 9:30 am in room 6A for session 705: cellular therapies in B-cell lymphomas! Very excited to present the clinical factors and global outcomes of Bridging therapy (BT) on Axi-cel for r/r LBCL ash.confex.com/ash/2023/webp…
1
140
Key Findings (1/2): -430 BT pts vs 877 no-BT -BT pts more likely >3 prior lines, < 12 mo primary dx to CAR, baseline hepatic impairment. IPTW done to balance groups -Real world BT heterogenous (R-GemOx 17%, Pola 13%, R-ICE 7% all others < 4%)
1
99
-after IPTW: no difference in ORR, CR, PFS, OS, CRS, ICANS, NRM. BT inc prolonged cytopenias -CR/PR to BT a/w improved PFS/OS to Axi-cel -chemo+anti-CD20 mAb, RT or non-chemo bridging (novel regimens) mainly equal safety and efficacy of Axi-cel #ASH2023
104
Michael Cook retweeted
#ASH23 @Michael_R_Cook4 from @PennMedicine discusses impact of bridging therapy (BT) prior to axi-cel treatment in pts with LBCL. N=1307; ORR with and without bridging therapy=70% vs 79%; CR= 51% vs 64% respectively. Grade ≥3 CRS and ICANS in BT vs no BT=12% and 30% vs 10% and 24%. The data suggests BT prior to axi-cel treatment does not impact safety or effectiveness of axi-cel but may increase prolonged cytopenias.
3
5
993
Michael Cook retweeted
Ouch. Bendamustine is bad news for CAR T-cells in FL too - figure below from just-published ZUMA-5 data in @BloodJournal as per @gloria_iacoboni I wonder whether this effect is overcome with BsAbs given repeat stimulation of the T-cells ashpublications.org/blood/ar… @AshAlizadeh
Check out the data published today on ZUMA-5 trial in Blood, figure 3 😉
1
7
2
36
9,044
Michael Cook retweeted
ASH is strongly urging @ABIMcert to take immediate action to establish a new MOC program that does not involve high-stakes assessments to better serve our members. Read the full text of ASH’s letter: loom.ly/xXS6uqQ @ABMSCert
10
76
22
221
85,207
RR #DLBCL #Lymphoma & secondary #CNS Involvement #CART #celltherapy has seen more #realworld data of late. Latest is the🇩🇪 #registry LONG-TERM #data from @NicoGagelmann & team 👍reassuring - outcomes comparable with those without, & no ⬆️in #ICANS or #CRS. ashpublications.org/bloodadv…
2
3
10
2,009
Michael Cook retweeted
Ladies and gentlemen, I present you with the worst take you’ll see all year.
Theory from @ProFootballTalk on @937theFan. Thinks the Steelers might not be making George Pickens the focal point of the offense because they don't want to create a "contractual monster". They don't want to pay him #1 WR money. 30+ million a year. Hmmm.
7
3
37
10,603
Final Version published in @BloodJournal, check it out! ashpublications.org/blood/ar…
3
8
1,542